GE HealthCare Technologies (NASDAQ:GEHC) Issues FY24 Earnings Guidance

GE HealthCare Technologies (NASDAQ:GEHC) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $4.20-4.35 for the period, compared to the consensus estimate of $4.27. GE HealthCare Technologies also updated its FY 2024 guidance to 4.200-4.350 EPS.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on GEHC shares. Bank of America lowered their price target on shares of GE HealthCare Technologies from $94.00 to $86.00 and set a neutral rating on the stock in a report on Wednesday, May 1st. Mizuho decreased their target price on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a buy rating on the stock in a report on Wednesday, May 1st. Finally, The Goldman Sachs Group assumed coverage on GE HealthCare Technologies in a report on Thursday, May 30th. They issued a neutral rating and a $87.00 price objective on the stock. Five analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of Moderate Buy and a consensus price target of $94.09.

GE HealthCare Technologies Trading Up 0.0 %

GE HealthCare Technologies stock traded up $0.04 during trading on Friday, hitting $83.44. The company’s stock had a trading volume of 2,986,428 shares, compared to its average volume of 2,926,614. The stock’s fifty day moving average is $78.91 and its 200 day moving average is $82.43. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.83 and a current ratio of 1.06. GE HealthCare Technologies has a 1-year low of $62.35 and a 1-year high of $94.50. The stock has a market capitalization of $38.10 billion, a price-to-earnings ratio of 24.40, a P/E/G ratio of 3.00 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, beating analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The company had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.88 billion. During the same quarter last year, the business earned $0.92 EPS. GE HealthCare Technologies’s revenue for the quarter was up .5% on a year-over-year basis. As a group, equities research analysts predict that GE HealthCare Technologies will post 4.27 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be given a $0.03 dividend. The ex-dividend date of this dividend is Friday, July 19th. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.51%.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Jan Makela sold 66,955 shares of the company’s stock in a transaction on Wednesday, May 15th. The stock was sold at an average price of $81.54, for a total value of $5,459,510.70. Following the transaction, the chief executive officer now owns 63,348 shares of the company’s stock, valued at $5,165,395.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other GE HealthCare Technologies news, CTO Taha Kass-Hout sold 3,300 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total value of $259,710.00. Following the completion of the transaction, the chief technology officer now directly owns 67,300 shares in the company, valued at $5,296,510. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Jan Makela sold 66,955 shares of the business’s stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $81.54, for a total transaction of $5,459,510.70. Following the sale, the chief executive officer now owns 63,348 shares in the company, valued at approximately $5,165,395.92. The disclosure for this sale can be found here. Insiders have sold 90,482 shares of company stock valued at $7,369,137 in the last quarter. Insiders own 0.27% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.